Primary Recipient

UNIVERSITY OF CHICAGO, THE

Amount

$98,000.00

Award Date

9/01/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

Receptor tyrosine kinases (RTKs) have been shown to be important as therapeutic targets againstlung cancer. However, even with the RTK epidermal growth factor receptor inhibition, the responsewith small molecule inhibitors is at best 5%-15% in refractory